Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 14, 2014; 20(30): 10432-10439
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10432
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10432
MiRNA as potential biomarkers and therapeutic targets for gastric cancer
Vivian Yvonne Shin, Kent-Man Chu, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China
Author contributions: Shin VY and Chu KM contributed to the writing of the manuscript.
Correspondence to: Kent-Man Chu, Professor, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, China. chukm@hku.hk
Telephone: +852-2255-4637 Fax: +852-2819-4221
Received: October 28, 2013
Revised: February 4, 2014
Accepted: April 27, 2014
Published online: August 14, 2014
Processing time: 293 Days and 22.7 Hours
Revised: February 4, 2014
Accepted: April 27, 2014
Published online: August 14, 2014
Processing time: 293 Days and 22.7 Hours
Core Tip
Core tip: This minireview summarized the most up-to-date important microRNAs (miRNAs) involved in tumor progression and development in gastric cancer. The potential use of miRNAs in the different areas of clinical settings is discussed.